Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature

The optimal second- and third-line chemotherapy and targeted therapy for patients with advanced esophagogastric cancer is still a matter of debate. Therefore, a literature search was carried out in Medline, EMBASE, CENTRAL, and oncology conferences until January 2016 for randomized controlled trials...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Metastasis Rev
Glavni autori: ter Veer, Emil, Haj Mohammad, Nadia, van Valkenhoef, Gert, Ngai, Lok Lam, Mali, Rosa M. A., van Oijen, Martijn G. H., van Laarhoven, Hanneke W. M.
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2016
Teme:
Clinical
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5035657/
https://ncbi.nlm.nih.gov/pubmed/27417221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10555-016-9632-2
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items